Assembly Biosciences (ASMB) Stock Price

Assembly Biosciences Price

NASDAQ·CLOSED
25.11USD-0.95 (-3.71 %)
Market closed

Revenue has compounded at 29.7% per year over the past 8 years to 72.30 M USD. Assembly Biosciences's net margin stands at -8.5%, up from -78.6% several years earlier. Analysts set a median price target of 45.90 USD, implying 82.8% above the current price. Of 10 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 33% above its 52-week low.

Assembly Biosciences stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Assembly Biosciences over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Assembly Biosciences stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Assembly Biosciences's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Assembly Biosciences Stock Price History
DateAssembly Biosciences Price
7/31/202625.11 USD
7/30/202626.06 USD
7/29/202624.97 USD
7/27/202626.34 USD
7/23/202625.22 USD
7/22/202626.04 USD
7/21/202626.47 USD
7/20/202625.06 USD
7/17/202626.81 USD
7/16/202625.84 USD
7/15/202626.73 USD
7/14/202626.76 USD
7/13/202627.11 USD
7/10/202627.40 USD
7/9/202627.87 USD
7/8/202628.78 USD
7/7/202628.97 USD
7/6/202627.78 USD
7/2/202627.74 USD
7/1/202626.69 USD
6/30/202627.48 USD
6/29/202626.96 USD
6/26/202626.74 USD
6/25/202624.26 USD
6/24/202625.62 USD
6/23/202626.80 USD
6/22/202625.31 USD
6/18/202624.32 USD
6/17/202624.31 USD
6/16/202623.08 USD
6/15/202623.23 USD
6/12/202622.96 USD
6/11/202621.88 USD
6/10/202623.11 USD
6/9/202622.72 USD
6/8/202622.56 USD
6/5/202622.90 USD
6/4/202624.11 USD
6/3/202624.57 USD
6/2/202624.49 USD
6/1/202626.92 USD
5/29/202627.66 USD
5/28/202627.73 USD
5/27/202627.40 USD
5/26/202628.75 USD
5/22/202628.34 USD
5/21/202626.50 USD
5/20/202626.26 USD
5/19/202626.52 USD
5/18/202627.42 USD
5/15/202628.65 USD
5/14/202630.30 USD
5/13/202631.72 USD
5/12/202630.82 USD
5/11/202630.41 USD
5/8/202629.74 USD
5/7/202630.93 USD
5/6/202631.36 USD
5/5/202629.55 USD
5/4/202627.82 USD
5/1/202627.37 USD
4/30/202626.95 USD
4/29/202626.33 USD
4/28/202627.00 USD
4/27/202627.52 USD
4/24/202627.87 USD
4/23/202627.91 USD
4/22/202628.30 USD
4/21/202626.95 USD
4/20/202628.13 USD
4/17/202629.24 USD
4/16/202629.32 USD
4/15/202629.81 USD
4/14/202629.44 USD
4/13/202629.24 USD
4/10/202628.42 USD
4/9/202629.85 USD
4/8/202629.35 USD
4/7/202628.53 USD
4/6/202629.22 USD
4/2/202629.01 USD
4/1/202629.43 USD
3/31/202627.75 USD
3/30/202626.64 USD
3/27/202627.70 USD
3/26/202628.87 USD
3/25/202628.67 USD
3/24/202628.23 USD
3/23/202628.58 USD
3/20/202628.46 USD
3/19/202627.51 USD
3/18/202627.52 USD
3/17/202628.53 USD
3/16/202628.74 USD
3/13/202628.12 USD
3/12/202628.30 USD
3/11/202629.21 USD
3/10/202629.60 USD
3/9/202629.13 USD
3/6/202628.27 USD
3/5/202627.66 USD
3/4/202629.79 USD
3/3/202628.80 USD
3/2/202629.68 USD
2/27/202629.84 USD
2/26/202629.59 USD
2/25/202629.34 USD
2/24/202629.64 USD
2/23/202629.95 USD
2/20/202628.75 USD
2/19/202625.97 USD
2/18/202628.89 USD
2/17/202627.82 USD
2/13/202626.66 USD
2/12/202626.09 USD
2/11/202627.36 USD
2/10/202627.48 USD
2/9/202626.90 USD
2/6/202626.22 USD
2/5/202625.39 USD
2/4/202627.05 USD
2/3/202628.24 USD
2/2/202626.37 USD
1/30/202625.78 USD
1/29/202625.71 USD
1/28/202626.42 USD
1/27/202627.52 USD
1/26/202627.34 USD
1/23/202628.01 USD
1/22/202627.62 USD
1/21/202626.35 USD
1/20/202626.80 USD
1/16/202629.37 USD
1/15/202629.91 USD
1/14/202632.04 USD
1/13/202631.60 USD
1/12/202630.93 USD
1/9/202631.74 USD
1/8/202631.56 USD
1/7/202631.39 USD
1/6/202630.58 USD
1/5/202632.31 USD
1/2/202633.75 USD
12/31/202534.01 USD
12/30/202532.13 USD
12/29/202533.32 USD
12/26/202533.62 USD
12/24/202534.00 USD
12/23/202532.73 USD
12/22/202536.18 USD
12/19/202535.26 USD
12/18/202532.35 USD
12/17/202532.58 USD
12/16/202533.50 USD
12/15/202534.60 USD
12/12/202536.10 USD
12/11/202535.88 USD
12/10/202535.87 USD
12/9/202535.67 USD
12/8/202535.38 USD
12/5/202535.01 USD
12/4/202535.27 USD
12/3/202535.00 USD
12/2/202533.99 USD
12/1/202533.89 USD
11/28/202537.79 USD
11/26/202537.19 USD
11/25/202537.42 USD
11/24/202537.93 USD
11/21/202538.50 USD
11/20/202536.73 USD
11/19/202538.00 USD
11/18/202535.89 USD
11/17/202536.33 USD
11/14/202536.71 USD
11/13/202535.52 USD
11/12/202535.85 USD
11/11/202533.13 USD
11/10/202532.07 USD
11/7/202531.20 USD
11/6/202531.21 USD
11/5/202532.11 USD
11/4/202531.43 USD
11/3/202531.17 USD
10/31/202531.05 USD
10/30/202530.12 USD
10/29/202530.99 USD
10/28/202530.89 USD
10/27/202529.80 USD
10/24/202529.24 USD
10/23/202527.50 USD
10/22/202528.15 USD
10/21/202528.41 USD
10/20/202530.79 USD
10/17/202529.45 USD
10/16/202529.08 USD
10/15/202528.44 USD
10/14/202528.39 USD
10/13/202527.66 USD
10/10/202526.51 USD
10/9/202526.82 USD
10/8/202525.50 USD
10/7/202523.86 USD
10/6/202524.48 USD
10/3/202523.32 USD
10/2/202523.70 USD
10/1/202524.61 USD
9/30/202525.60 USD
9/29/202524.63 USD
9/26/202524.67 USD
9/25/202525.53 USD
9/24/202525.66 USD
9/23/202525.99 USD
9/22/202524.78 USD
9/19/202524.46 USD
9/18/202522.27 USD
9/17/202520.62 USD
9/16/202520.55 USD
9/15/202521.19 USD
9/12/202521.85 USD
9/11/202522.59 USD
9/10/202522.26 USD
9/9/202523.15 USD
9/8/202523.32 USD
9/5/202523.82 USD
9/4/202523.31 USD
9/3/202523.90 USD
9/2/202524.13 USD
8/29/202524.70 USD
8/28/202525.50 USD
8/27/202525.89 USD
8/26/202525.62 USD
8/25/202526.62 USD
8/22/202526.93 USD
8/21/202526.65 USD
8/20/202526.15 USD
8/19/202525.22 USD
8/18/202525.76 USD
8/15/202525.44 USD
8/14/202524.96 USD
8/13/202524.75 USD
8/12/202523.99 USD
8/11/202523.60 USD
8/8/202523.97 USD
8/7/202521.22 USD
8/6/202519.43 USD
8/5/202518.86 USD
Access this data via the Eulerpool API
Get Free API Key

Assembly Biosciences Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
7.16 M USD
-64.65 M USD
-61.23 M USD
Jan 1, 2024
28.52 M USD
-45.42 M USD
-40.18 M USD
Jan 1, 2025
72.30 M USD
-12.12 M USD
-6.12 M USD
Jan 1, 2026 (e)
45.52 M USD
-18.98 M USD
-26.92 M USD
Jan 1, 2027 (e)
43.00 M USD
-17.93 M USD
-50.77 M USD
Jan 1, 2028 (e)
65.50 M USD
-27.31 M USD
-39.51 M USD
Jan 1, 2029 (e)
28.00 M USD
-11.67 M USD
-59.85 M USD
Jan 1, 2030 (e)
123.83 M USD
-51.63 M USD
-36.12 M USD

Assembly Biosciences Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 5, 2026, 9:57 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201520162017201820192020202120222023202420252026e2027e2028e2029e2030e
––9.0014.0015.0079.006.00–7.0028.0072.0045.0043.0065.0028.00123.00
–––55.567.14426.67-92.41––300.00157.14-37.50-4.4451.16-56.92339.29
––-388.89-407.14100.00-27.85100.00–-585.71-96.43100.00100.00100.00100.00100.00100.00
72.0072.00-35.00-57.0015.00-22.006.0072.00-41.00-27.0072.0045.0043.0065.0028.00123.00
-29.00-45.00-52.00-92.00-102.00-64.00-132.00-94.00-64.00-45.00-12.00-18.00-17.00-27.00-11.00-51.00
––-577.78-657.14-680.00-81.01-2,200.00–-914.29-160.71-16.67-40.00-39.53-41.54-39.29-41.46
-28.00-44.00-42.00-90.00-97.00-62.00-129.00-92.00-61.00-40.00-6.00-26.00-50.00-39.00-59.00-36.00
21.7457.14-4.55114.297.78-36.08108.06-28.68-33.70-34.43-85.00333.3392.31-22.0051.28-38.98
1.721.732.022.573.513.974.564.075.486.5811.2111.2111.2111.2111.2111.21
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Assembly Biosciences generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Assembly Biosciences retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Assembly Biosciences's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Assembly Biosciences has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Assembly Biosciences's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Assembly Biosciences stock margins

The Assembly Biosciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Assembly Biosciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Assembly Biosciences.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
100.00 %
-2,121.65 %
-2,076.35 %
Jan 1, 2022
99.82 %
- %
- %
Jan 1, 2023
-582.67 %
-902.50 %
-854.78 %
Jan 1, 2024
-96.12 %
-159.26 %
-140.87 %
Jan 1, 2025
99.82 %
-16.76 %
-8.47 %
Jan 1, 2026 (e)
99.82 %
-41.69 %
-59.13 %
Jan 1, 2027 (e)
99.82 %
-41.69 %
-118.07 %
Jan 1, 2028 (e)
99.82 %
-41.69 %
-60.33 %

Assembly Biosciences Stock Revenue, EBIT, Earnings per Share

The Assembly Biosciences earnings per share therefore indicates how much revenue Assembly Biosciences has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
1.37 USD
-29.12 USD
-28.50 USD
Jan 1, 2022
0.00 USD
-23.15 USD
-22.64 USD
Jan 1, 2023
1.31 USD
-11.79 USD
-11.17 USD
Jan 1, 2024
4.33 USD
-6.90 USD
-6.10 USD
Jan 1, 2025
6.45 USD
-1.08 USD
-0.55 USD
Jan 1, 2026 (e)
2.88 USD
-1.69 USD
-1.70 USD
Jan 1, 2027 (e)
2.72 USD
-1.60 USD
-3.21 USD
Jan 1, 2028 (e)
4.14 USD
-2.44 USD
-2.50 USD

Assembly Biosciences business model & stock analysis

Assembly Biosciences Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Assembly Biosciences Employees
Details
Date
Assembly Biosciences Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Assembly Biosciences Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Assembly Biosciences historical P/E ratio, EBIT multiple, and P/S ratio

Assembly Biosciences annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Assembly Biosciences shares outstanding

The number of shares of Assembly Biosciences was 11.21 M in 2025. This indicates how many shares Assembly Biosciences is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
4.56 M Stocks
Jan 1, 2022
4.07 M Stocks
Jan 1, 2023
5.48 M Stocks
Jan 1, 2024
6.58 M Stocks
Jan 1, 2025
11.21 M Stocks
Jan 1, 2026 (e)
11.21 M Stocks
Jan 1, 2027 (e)
11.21 M Stocks
Jan 1, 2028 (e)
11.21 M Stocks

Assembly Biosciences stock splits

In Assembly Biosciences's history, there have been no stock splits.

Current Assembly Biosciences forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
90.00 % (9)
Hold
10.00 % (1)
Sell
0.00 % (0)
12M Price Target
45.90
Last Price
25.93
Currency
USD
12M Return Potential
77.02 %
LTM Return
0 %

Assembly Biosciences Analyst Rating Actions

DateFirmActionRatingReliability
6/15/2026
Mizuho
Mizuho
MaintainedOutperform31
5/28/2026
Guggenheim
Guggenheim
MaintainedBuy30
5/4/2026
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
4/6/2026
Guggenheim
Guggenheim
MaintainedBuy30
3/26/2026
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
12/22/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
11/20/2025
Mizuho
Mizuho
MaintainedOutperform31
10/14/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedBuy–
9/8/2025
Guggenheim
Guggenheim
MaintainedBuy30
3/24/2025
HC Wainwright & Co.
HC Wainwright & Co.
MaintainedNeutral–

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Assembly Biosciences Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/4/2026-0.63USD-8.77 MUSD-2026 Q2
5/6/2026-0.58USD-9.45 MUSD-2026 Q1
3/18/2026-0.66USD-7.57 MUSD-2025 Q4
11/6/2024-1.89USD-8.96 MUSD-2024 Q3
5/2/2024-0.28USD-0.00USD-2024 Q1
3/20/2024-0.24USD-0.00USD-2023 Q4
8/7/2023-0.56USD-0.00USD-2023 Q2
5/10/2023-0.57USD-0.00USD-2023 Q1
3/8/2023-0.48USD-0.00USD-2022 Q4
11/8/2022-0.48USD-0.00USD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the Assembly Biosciences stock

77/100
53
Environment
99
Social
78
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees47
Percentage of women in management—
Percentage of Asian employees40
Share of Asian management—
Percentage of Hispanic/Latino employees5
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees51
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Assembly Biosciences shareholder structure

% Name
28.47908%
Gilead Sciences Inc
Gilead Sciences Inc
7.20929%
Farallon Capital Management, L.L.C.
Farallon Capital Management, L.L.C.
6.32111%
Commodore Capital LP
Commodore Capital LP
3.43567%
Schornstein (Alexander)
Schornstein (Alexander)
1.60446%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
1.19690%
B Group, Inc.
B Group, Inc.

Assembly Biosciences Beneficial Ownership Filings (SEC 13D/G)

Free Float
54.1%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
25.10%
GILEAD SCIENCES, INC.
GILEAD SCIENCES, INC.
SEC ↗
11.00%
see the Notes).
see the Notes).
SEC ↗
11.00%
Oleg Nodelman
Oleg Nodelman
SEC ↗
11.00%
EcoR1 Capital, LLC
EcoR1 Capital, LLC
SEC ↗
11.00%
EcoR1 Capital Fund Qualified, L.P.
EcoR1 Capital Fund Qualified, L.P.
SEC ↗
11.00%
Identification #52-2069785 (formerly 13-2631108)
Identification #52-2069785 (formerly 13-2631108)
SEC ↗
9.90%
Commodore Capital LP
Commodore Capital LP
SEC ↗
9.50%
RA Capital Management, L.P.
RA Capital Management, L.P.
SEC ↗
8.20%
JANUS HENDERSON GROUP PLC
JANUS HENDERSON GROUP PLC
SEC ↗
6.27%
Deep Track Capital, LP
Deep Track Capital, LP
SEC ↗

Assembly Biosciences Executives and Management Board

14 members · avg. age 60 · 36 % women

JO

Mr. Jason Okazaki (49)

President, Principal Executive Officer, Director · since 2020

1.77 M USD

Management

WD

Dr. William Delaney (53)

Chief Scientific Officer

963,467.00 USD
NW

Dr. Nicole White (45)

Chief Manufacturing Officer

827,537.00 USD
JB

Ms. Jeanette Bjorkquist

Principal Financial Officer, Principal Accounting Officer

–
AG

Dr. Anuj Gaggar (47)

Chief Medical Officer

–

Board of Directors

WR

Mr. William Ringo (79)

Non-Executive Independent Chairman of the Board

139,251.00 USD
AA

Mr. Anthony Altig (69)

Independent Director

96,751.00 USD
SM

Dr. Susan Mahony (60)

Independent Director

91,751.00 USD
GC

Ms. Gina Consylman (53)

Independent Director

89,251.00 USD
JM

Dr. John Mchutchison (67)

Director · since 2019

81,751.00 USD
LJ

Dr. Lisa Johnson-Pratt (61)

Independent Director

81,751.00 USD

Frequently asked questions about Assembly Biosciences

Analysts currently set an average price target of 46.67 USD for the Assembly Biosciences stock (median: 45.90 USD), implying +80.0 % versus the latest price. The consensus is based on 10 analyst ratings.

Assembly Biosciences Analyst Price Targets 2026

10 analysts currently rate the Assembly Biosciences stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Assembly Biosciences to generate revenue of 45.52 M USD and earnings per share of -2.40 USD.

Assembly Biosciences Analyst Price Targets 2026

Converted at the current exchange rate, the Assembly Biosciences share trades at 21.79 EUR (25.11 USD).

The Assembly Biosciences share (ASMB) is listed on 4 stock exchanges, including: NASDAQ (ASMB), Frankfurt (V7B1.F), München (V7B1.MU), Düsseldorf (V7B1.DU).

No history available for Assembly Biosciences.

The expected revenue of Assembly Biosciences is 45.52 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Assembly Biosciences is -26.92 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Assembly Biosciences is currently -10.46. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Assembly Biosciences stock.

The price-to-sales ratio (P/S) of Assembly Biosciences is currently 6.18. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Assembly Biosciences stock.

The Eulerpool Quality Score for Assembly Biosciences is 4/10.

The ISIN of Assembly Biosciences is US0453962070. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Assembly Biosciences is A117S1. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Assembly Biosciences is ASMB. The ticker symbol is used to trade Assembly Biosciences shares on the stock exchange.

Assembly Biosciences paid dividends every year for the past 0 years.

Assembly Biosciences is assigned to the 'Health' sector.

The dividends of Assembly Biosciences are distributed in USD.

All fundamentals and in-depth analysis of Assembly Biosciences

Our stock analysis for Assembly Biosciences stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Assembly Biosciences. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Assembly Biosciences Stock
Assembly Biosciences Revenue→
Assembly Biosciences Stock
Assembly Biosciences Net Income→
Assembly Biosciences Stock
Assembly Biosciences P/E→
Assembly Biosciences Stock
Assembly Biosciences P/S→
Assembly Biosciences Stock
Assembly Biosciences EBIT→
Assembly Biosciences Stock
Assembly Biosciences Dividend→
Assembly Biosciences Stock
Assembly Biosciences Directors Dealings→
Assembly Biosciences Stock
Assembly Biosciences Stocks→
Assembly Biosciences Stock
Assembly Biosciences Market capitalization→
Assembly Biosciences Stock
Assembly Biosciences Debt→
Assembly Biosciences Stock
Assembly Biosciences Liabilities→
Assembly Biosciences Stock
Assembly Biosciences Equity→
Assembly Biosciences Stock
Assembly Biosciences AAQS→
Assembly Biosciences Stock
Assembly Biosciences Employees→
Assembly Biosciences Stock
Assembly Biosciences ROE→
Assembly Biosciences Stock
Assembly Biosciences ROA→
Assembly Biosciences Stock
Assembly Biosciences ROCE→
Assembly Biosciences Stock
Assembly Biosciences News→
Assembly Biosciences Stock
Assembly Biosciences Analyst Price Targets→

Health Stocks

Assure Tech (Hangzhou) CoAspen Pharmacare HoldingsAsta CoAso InternationalAstellas PharmaAsker Healthcare GroupAstena Holdings CoASKA Pharmaceutical Holdings CoAster DM HealthcareAsiaMedicAstrana HealthAsia Vets HoldingsAll Stocks A–Z →